STOCK TITAN

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

electroCore (NASDAQ: ECOR), a bioelectronic medicine and wellness company, has scheduled its Q2 2025 financial results announcement for Wednesday, August 6, 2025, after market close.

The company will host an interactive webinar at 4:30 PM EDT where management will review financial results and take questions from participants. Investors can join using the dial-in number (646) 931-3860, with Webinar ID 843 8084 9004 and Passcode 049555.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+4.27%
1 alert
+4.27% News Effect

On the day this news was published, ECOR gained 4.27%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2025, after the close of the market on Wednesday, August 6, 2025.

Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:

Wednesday, August 6, 4:30 PM EDT
Dial-In: (646) 931-3860
Webinar ID: 843 8084 9004
Passcode: 049555
Registration Link: Click here to participate and ask questions on the call.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator. Additionally, the company commercializes its Truvaga products, handheld, and personal use nVNS products utilizing bioelectronic technologies, to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact

ECOR Investor Relations
(973) 302-9253
investors@electrocore.com


FAQ

When will electroCore (ECOR) report Q2 2025 earnings?

electroCore will report Q2 2025 earnings on Wednesday, August 6, 2025, after the market close.

How can investors join electroCore's Q2 2025 earnings call?

Investors can join via webinar at 4:30 PM EDT using dial-in number (646) 931-3860, Webinar ID 843 8084 9004, and Passcode 049555.

What period will electroCore's upcoming earnings report cover?

The earnings report will cover the second quarter ended June 30, 2025.

What type of company is electroCore (ECOR)?

electroCore is a commercial-stage bioelectronic medicine and wellness company.
Electrocore

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Latest SEC Filings

ECOR Stock Data

55.01M
5.14M
37.28%
15.51%
5.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY